Toni Choueiri received the Lifetime Achievement Award at The King Hussein Cancer Foundation Annual Celebration

Toni Choueiri from Dana-Farber Cancer Institute Honored with Lifetime Achievement Award at The King Hussein Cancer Foundation Annual Celebration.

Toni K. Choueiri is a renowned medical oncologist, clinical trialist, and translational researcher, specializing in the treatment of genitourinary (GU) cancers, with a particular focus on kidney cancer. He currently serves as the Director of the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute (DFCI), one of the world’s leading cancer centers. In addition to his role at Dana-Farber, Dr. Choueiri is the co-leader of the Kidney Cancer Program at the Dana-Farber/Harvard Cancer Center, which is one of the most prominent academic cancer research centers in the U.S.

Dr. Choueiri holds the prestigious Jerome and Nancy Kohlberg Chair in Oncology and is a Professor of Medicine at Harvard Medical School. His expertise lies not only in treating a wide array of genitourinary cancers, including prostate, bladder, testicular, and kidney cancer, but also in leading innovative clinical trials and conducting cutting-edge translational research aimed at improving the lives of patients with these cancers. Dr. Choueiri has been a leader in advancing therapies for kidney cancer, particularly in the areas of targeted therapies and immunotherapy, and he has played a pivotal role in the development and testing of new drugs and treatment regimens.

Throughout his career, Dr. Choueiri has contributed extensively to the scientific community through numerous publications and has been instrumental in shaping the field of GU oncology. His research has focused on understanding the biology of kidney cancer and translating this knowledge into more effective, personalized treatment strategies. Dr. Choueiri is also known for his leadership in clinical trials, working to bring promising new therapies to the forefront of cancer treatment.

About The King Hussein Cancer Foundation Lifetime Achievement Award

The King Hussein Award is a prestigious recognition established to honor individuals who have made significant contributions to advancing cancer research and treatment both in the Arab region and internationally. The award specifically acknowledges the pioneers and leaders in oncology who have played critical roles in advancing regional research and promoting the fight against cancer on a global scale.

The Lifetime Achievement Award is the centerpiece of this award, recognizing exceptional individuals whose work has had a lasting impact on the field of cancer research, care, and awareness. The award is intended to highlight the contributions of researchers, clinicians, and advocates who have shown unwavering dedication to improving cancer treatment and outcomes, especially in the Arab world. By honoring these distinguished individuals, the King Hussein Award aims to inspire further progress in cancer care and foster collaboration between the Arab world and international cancer research communities.

The King Hussein Award not only serves to celebrate outstanding achievements in oncology but also aims to inspire continued collaboration, knowledge-sharing, and capacity-building within the Arab world and globally. Through these efforts, the award supports the overall mission of the King Hussein Cancer Foundation (KHCF), which seeks to improve cancer care, raise awareness, and drive forward research innovation in the fight against cancer.

About The King Hussein Cancer Foundation (KHCF) and Center (KHCC)

The King Hussein Cancer Foundation (KHCF) and Center (KHCC) is an independent, non-governmental, non-profit institution based in Jordan. Established in 2001 by a royal decree, the foundation is dedicated to combating cancer through a range of initiatives, including awareness, prevention, and early detection programs. Its mission extends to providing comprehensive care to cancer patients not only from Jordan but also from across the Arab world. Under the leadership of Princess Ghida Talal, the foundation plays a pivotal role in advancing cancer care and treatment in the region.

In addition to offering state-of-the-art medical services, the KHCF and KHCC focus on promoting research and innovation in oncology. The center is committed to enhancing patient care through the development of new therapies, while also providing a platform for education and collaboration in the broader scientific community. With its focus on holistic care and its vision for a cancer-free future, KHCF and KHCC have become leading institutions in the Middle East for the treatment and prevention of cancer.